HUP0001652A2 - Oxadiazolszármazékok, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények - Google Patents
Oxadiazolszármazékok, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítményekInfo
- Publication number
- HUP0001652A2 HUP0001652A2 HU0001652A HUP0001652A HUP0001652A2 HU P0001652 A2 HUP0001652 A2 HU P0001652A2 HU 0001652 A HU0001652 A HU 0001652A HU P0001652 A HUP0001652 A HU P0001652A HU P0001652 A2 HUP0001652 A2 HU P0001652A2
- Authority
- HU
- Hungary
- Prior art keywords
- oxadiazole derivatives
- processes
- preparation
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 150000004866 oxadiazoles Chemical class 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 201000006474 Brain Ischemia Diseases 0.000 abstract 1
- 206010008120 Cerebral ischaemia Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 206010008118 cerebral infarction Diseases 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 125000002541 furyl group Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Veterinary Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
A találmány tárgyát az (I) általános képletű oxadiazolszármazékok -ahol a szubsztituensek jelentése többek között: X és Y oxigén- vagynitrogénatom, azzal a megszorítással, hogy X és Y mindig különbözőjelentésű, Z szubsztituált fenil-, piridil-, furil-, tienil- vagykondenzált vázas heterociklusos csoport, és R1 szubsztituált fenil-,cikloalkil-, spiroalkilcsoport - eljárás az előállításukra, valamint aneurodegeneratív betegségek és a különböző eredetű agyi ischaemiakezelésére alkalmas gyógyszerkészítmények hatóanyagaként valófelhasználásuk képezi. Ó
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19643037A DE19643037A1 (de) | 1996-10-18 | 1996-10-18 | Neue Oxadiazole, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0001652A2 true HUP0001652A2 (hu) | 2001-01-29 |
HUP0001652A3 HUP0001652A3 (en) | 2002-12-28 |
Family
ID=7809114
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0001652A HUP0001652A3 (en) | 1996-10-18 | 1997-10-15 | Oxadiazole derivatives, processes for their preparation, their use and pharmaceutical compositions containing them |
Country Status (32)
Country | Link |
---|---|
US (1) | US6277872B1 (hu) |
EP (1) | EP0934288B1 (hu) |
JP (1) | JP3333523B2 (hu) |
KR (1) | KR20000049253A (hu) |
CN (1) | CN1086698C (hu) |
AR (1) | AR008496A1 (hu) |
AT (1) | ATE315034T1 (hu) |
AU (1) | AU737552B2 (hu) |
BG (1) | BG103251A (hu) |
BR (1) | BR9714354A (hu) |
CA (1) | CA2268954C (hu) |
CO (1) | CO4920253A1 (hu) |
CZ (1) | CZ138099A3 (hu) |
DE (2) | DE19643037A1 (hu) |
EE (1) | EE9900147A (hu) |
ES (1) | ES2256880T3 (hu) |
HK (1) | HK1020956A1 (hu) |
HR (1) | HRP970553A2 (hu) |
HU (1) | HUP0001652A3 (hu) |
ID (1) | ID18613A (hu) |
IL (1) | IL129315A0 (hu) |
NO (1) | NO312512B1 (hu) |
NZ (1) | NZ335598A (hu) |
PE (1) | PE11199A1 (hu) |
PL (1) | PL332432A1 (hu) |
RU (1) | RU2182905C2 (hu) |
SK (1) | SK49999A3 (hu) |
TR (1) | TR199900848T2 (hu) |
TW (1) | TW413678B (hu) |
WO (1) | WO1998017652A1 (hu) |
YU (1) | YU40997A (hu) |
ZA (1) | ZA979220B (hu) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19816880A1 (de) | 1998-04-17 | 1999-10-21 | Boehringer Ingelheim Pharma | Neue Diphenyl-substituierte 5-Ring-Heterocyclen, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel |
IT1300056B1 (it) * | 1998-04-17 | 2000-04-05 | Boehringer Ingelheim Italia | Eterocicli con anello a 6 termini difenil-sostituiti loro procedimento di preparazione e loro impiego come farmaci |
US6107313A (en) * | 1998-10-02 | 2000-08-22 | Combichem, Inc. | Dopamine receptor antagonists |
WO2000047567A1 (fr) | 1999-02-15 | 2000-08-17 | Eisai Co., Ltd. | Derives d'heterodiazinone |
DE60007697T2 (de) | 1999-07-21 | 2004-12-09 | F. Hoffmann-La Roche Ag | Triazolderivate |
EP1582519A3 (en) * | 1999-08-19 | 2005-12-21 | Nps Pharmaceuticals, Inc. | Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
US6660753B2 (en) | 1999-08-19 | 2003-12-09 | Nps Pharmaceuticals, Inc. | Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
HUP0202757A3 (en) * | 1999-08-19 | 2006-03-28 | Nps Pharmaceuticals Inc Salt L | Heteropolycyclic compounds, pharmaceutical compositions containing them and their use as metabotropic glutamate receptor antagonists |
US6579880B2 (en) * | 2000-06-06 | 2003-06-17 | Ortho-Mcneil Pharmaceutical, Inc. | Isoxazoles and oxadiazoles as anti-inflammatory inhibitors of IL-8 |
HU1300187D0 (hu) | 2000-06-12 | 2004-03-01 | Eisai R&D Man Co Ltd | 1,2-Dihidropiridin-származékok, eljárás elõállításukra és alkalmazásuk |
KR100770327B1 (ko) * | 2000-09-18 | 2007-10-25 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 피리다지논 및 트리아지논 화합물류 및 그들의 의약 용도 |
RU2319701C2 (ru) * | 2001-02-21 | 2008-03-20 | Астразенека Аб | ГЕТЕРОПОЛИЦИКЛИЧЕСКОЕ СОЕДИНЕНИЕ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ОБЛАДАЮЩАЯ АНТАГОНИСТИЧЕСКОЙ АКТИВНОСТЬЮ В ОТНОШЕНИИ МЕТАБОТРОПНЫХ ГЛЮТАМАТНЫХ РЕЦЕПТОРОВ mGluR ГРУППЫ I |
JP4303109B2 (ja) * | 2001-10-04 | 2009-07-29 | メルク エンド カムパニー インコーポレーテッド | 代謝共役型グルタミン酸受容体−5のヘテロアリール置換テトラゾール調節剤 |
MY151199A (en) | 2001-11-02 | 2014-04-30 | Rigel Pharmaceuticals Inc | Substituted diphenyl heterocycles useful for treating hcv infection |
GB0129260D0 (en) | 2001-12-06 | 2002-01-23 | Eisai London Res Lab Ltd | Pharmaceutical compositions and their uses |
WO2004018463A2 (en) | 2002-08-23 | 2004-03-04 | Rigel Pharmaceuticals, Inc. | Pyridyl substituted heterocycles useful for treating or preventing hcv infection |
GB0303503D0 (en) * | 2003-02-14 | 2003-03-19 | Novartis Ag | Organic compounds |
US7115642B2 (en) | 2003-05-02 | 2006-10-03 | Rigel Pharmaceuticals, Inc. | Substituted diphenyl isoxazoles, pyrazoles and oxadiazoles useful for treating HCV infection |
EP1620412A2 (en) | 2003-05-02 | 2006-02-01 | Rigel Pharmaceuticals, Inc. | Heterocyclic compounds and hydro isomers thereof |
US7220745B2 (en) | 2003-05-15 | 2007-05-22 | Rigel Pharmaceuticals | Heterocyclic compounds useful to treat HCV |
WO2005049065A2 (en) | 2003-11-19 | 2005-06-02 | Rigel Pharmaceuticals, Inc. | Synergistic combinations of dihaloacetamide with interferon or ribavirin for treatment hcv infections |
NZ547965A (en) | 2003-12-24 | 2009-12-24 | Prosidion Ltd | 1,2,4-Oxadiazole derivatives as GPCR receptor agonists |
US7514434B2 (en) | 2004-02-23 | 2009-04-07 | Rigel Pharmaceuticals, Inc. | Heterocyclic compounds having an oxadiazole moiety and hydro isomers thereof |
MY148809A (en) | 2004-07-06 | 2013-05-31 | Eisai R&D Man Co Ltd | Crystals of 1,2-dihydropyridine compound and their production process |
JPWO2006109876A1 (ja) * | 2005-04-08 | 2008-11-20 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 不随意運動治療剤 |
WO2007027230A2 (en) | 2005-05-02 | 2007-03-08 | Rigel Pharmaceuticals, Inc. | Heterocyclic anti-viral compounds comprising metabolizable moieties and their uses |
GB0510142D0 (en) * | 2005-05-18 | 2005-06-22 | Addex Pharmaceuticals Sa | Novel compounds A1 |
HUP0500920A2 (en) * | 2005-10-05 | 2007-07-30 | Richter Gedeon Nyrt | Oxadiazole derivatives, process for their preparation and their use |
CA2672616A1 (en) * | 2006-12-15 | 2008-06-26 | Abbott Laboratories | Novel oxadiazole compounds |
US20110207704A1 (en) * | 2006-12-15 | 2011-08-25 | Abbott Laboratories | Novel Oxadiazole Compounds |
JO2701B1 (en) | 2006-12-21 | 2013-03-03 | جلاكسو جروب ليميتد | Vehicles |
JP5727223B2 (ja) * | 2007-10-04 | 2015-06-03 | メルク セローノ ソシエテ アノニム | オキサジアゾール・ジアリール化合物 |
US9045442B2 (en) * | 2007-12-21 | 2015-06-02 | University Of Notre Dame Du Lac | Antibacterial compounds and methods of using same |
AU2009266098B2 (en) | 2008-06-09 | 2015-01-22 | Ludwig-Maximilians-Universitat Munchen | New drug for inhibiting aggregation of proteins involved in diseases linked to protein aggregation and/or neurodegenerative diseases |
WO2011047129A1 (en) * | 2009-10-15 | 2011-04-21 | Southern Research Institute | Treatment of neurodegenerative diseases, causation of memory enhancement, and assay for screening compounds for such |
RU2641293C2 (ru) * | 2012-08-24 | 2018-01-17 | Тревентис Корпорейшн | Бензофуразановые антимилоидные соединения и способы |
PT3110812T (pt) | 2014-02-27 | 2019-07-10 | Treventis Corp | Compostos antiamiloide contendo benzofurazano |
CN106231905B (zh) | 2014-04-24 | 2019-04-09 | 住友化学株式会社 | 二芳基-唑化合物 |
CA2962431A1 (en) | 2014-09-25 | 2016-03-31 | University Of Notre Dame Du Lac | Non-beta lactam antibiotics |
CN107286174B (zh) * | 2016-04-11 | 2020-08-18 | 上海勋和医药科技有限公司 | 取代2,4-(1h,3h)嘧啶二酮作为parp抑制剂及其应用 |
US11168062B2 (en) | 2016-09-12 | 2021-11-09 | University Of Notre Dame Du Lac | Compounds for the treatment of Clostridium difficile infection |
JP7283699B2 (ja) | 2017-05-12 | 2023-05-30 | マックス-プランク-ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ | 黒色腫の治療または予防において使用するためのフェニル-ヘテロ環-フェニル誘導体 |
US10676467B2 (en) | 2017-06-30 | 2020-06-09 | Washington University | Compositions for binding sphingosine-1-phosphate receptor 1 (S1P1), imaging of S1P1, and methods of use thereof |
US20220023275A1 (en) | 2018-12-14 | 2022-01-27 | Eisai R&D Management Co., Ltd. | Aqueous Based Pharmaceutical Formulations of 1,2-Dihydropyridine Compounds |
WO2023042887A1 (ja) | 2021-09-15 | 2023-03-23 | 国立大学法人 琉球大学 | 認知機能低下、または過体重もしくは肥満症を処置することに用いるための医薬組成物 |
EP4403185A1 (en) | 2021-09-15 | 2024-07-24 | University of The Ryukyus | Pharmaceutical composition for treating cognitive decline or for treating overweightness or obesity |
EP4173485A1 (en) | 2021-10-27 | 2023-05-03 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Protein aggregation inhibiting compounds for plant disease control |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4003909A (en) * | 1974-07-22 | 1977-01-18 | E. R. Squibb & Sons, Inc. | [(1,2,4-Oxadiazol-3-yl)phenyl]carbamic or thiocarbamic acid esters |
JPS52272A (en) * | 1975-10-17 | 1977-01-05 | Takeda Chem Ind Ltd | Process for preparing 1,2,4-oxadiazole derivatives |
DE2801509A1 (de) * | 1978-01-12 | 1979-07-19 | Schering Ag | 1,2,4-oxadiazolderivate, verfahren zur herstellung dieser verbindungen sowie diese enthaltende selektive herbizide mittel |
JPS58150576A (ja) * | 1982-03-03 | 1983-09-07 | Sumitomo Chem Co Ltd | 新規な1,2,4−オキサジアゾ−ル誘導体 |
EP0276432A3 (de) * | 1986-12-12 | 1988-10-26 | Ciba-Geigy Ag | Schädlingsbekämpfungsmittel |
DE3905242A1 (de) * | 1989-02-21 | 1990-08-23 | Basf Ag | Verfahren zur herstellung von phenyloxdiazolylanilinen |
JPH02250873A (ja) * | 1989-03-24 | 1990-10-08 | Mitsubishi Petrochem Co Ltd | 1,2,4―オキサジアゾール誘導体及びそれを有効成分とする除草剤 |
NZ234760A (en) * | 1989-08-18 | 1991-09-25 | Sterling Drug Inc | Antiviral oxazole compounds and compositions |
DK443489D0 (da) * | 1989-09-08 | 1989-09-08 | Ferrosan As | Substituerede urinstofforbindelser, deres fremstilling og anvendelse |
JPH04295470A (ja) * | 1991-03-22 | 1992-10-20 | Wakamoto Pharmaceut Co Ltd | モノアミンオキシダーゼ−b酵素阻害活性を有する1,2,4−オキサジアゾール誘導体及びその製造法 |
WO1993002677A1 (en) * | 1991-08-03 | 1993-02-18 | Smithkline Beecham Plc | 5-ht4 receptor antagonists |
DE4401107A1 (de) * | 1994-01-17 | 1995-07-20 | Bayer Ag | 3-Aryl-alkenyl-1,2,4-oxadiazol-Derivate |
DE4401108A1 (de) * | 1994-01-17 | 1995-07-20 | Bayer Ag | 1,2,4-Oxadiazol-Derivate |
DE19528189A1 (de) * | 1995-08-01 | 1997-02-06 | Basf Ag | Benzolderivate mit einem heterocyclischen Rest |
-
1996
- 1996-10-18 DE DE19643037A patent/DE19643037A1/de not_active Withdrawn
-
1997
- 1997-10-15 CZ CZ991380A patent/CZ138099A3/cs unknown
- 1997-10-15 NZ NZ335598A patent/NZ335598A/en unknown
- 1997-10-15 PE PE1997000910A patent/PE11199A1/es not_active Application Discontinuation
- 1997-10-15 JP JP50563998A patent/JP3333523B2/ja not_active Expired - Lifetime
- 1997-10-15 WO PCT/EP1997/005693 patent/WO1998017652A1/de active IP Right Grant
- 1997-10-15 EP EP97911227A patent/EP0934288B1/de not_active Expired - Lifetime
- 1997-10-15 EE EEP199900147A patent/EE9900147A/xx unknown
- 1997-10-15 SK SK499-99A patent/SK49999A3/sk unknown
- 1997-10-15 DE DE59712543T patent/DE59712543D1/de not_active Expired - Lifetime
- 1997-10-15 AU AU48676/97A patent/AU737552B2/en not_active Ceased
- 1997-10-15 ZA ZA9709220A patent/ZA979220B/xx unknown
- 1997-10-15 KR KR1019990703360A patent/KR20000049253A/ko not_active Application Discontinuation
- 1997-10-15 AT AT97911227T patent/ATE315034T1/de active
- 1997-10-15 PL PL97332432A patent/PL332432A1/xx unknown
- 1997-10-15 RU RU99111781/04A patent/RU2182905C2/ru not_active IP Right Cessation
- 1997-10-15 TR TR1999/00848T patent/TR199900848T2/xx unknown
- 1997-10-15 US US09/284,382 patent/US6277872B1/en not_active Expired - Lifetime
- 1997-10-15 HU HU0001652A patent/HUP0001652A3/hu unknown
- 1997-10-15 IL IL12931597A patent/IL129315A0/xx unknown
- 1997-10-15 ES ES97911227T patent/ES2256880T3/es not_active Expired - Lifetime
- 1997-10-15 CN CN97198866A patent/CN1086698C/zh not_active Expired - Fee Related
- 1997-10-15 BR BR9714354-5A patent/BR9714354A/pt not_active IP Right Cessation
- 1997-10-15 CA CA002268954A patent/CA2268954C/en not_active Expired - Fee Related
- 1997-10-16 ID IDP973449A patent/ID18613A/id unknown
- 1997-10-16 YU YU40997A patent/YU40997A/sh unknown
- 1997-10-16 HR HR19643037.2A patent/HRP970553A2/hr not_active Application Discontinuation
- 1997-10-17 CO CO97061157A patent/CO4920253A1/es unknown
- 1997-10-17 AR ARP970104812A patent/AR008496A1/es not_active Application Discontinuation
- 1997-10-18 TW TW086115386A patent/TW413678B/zh not_active IP Right Cessation
-
1999
- 1999-03-15 BG BG103251A patent/BG103251A/xx active Pending
- 1999-04-16 NO NO19991815A patent/NO312512B1/no not_active IP Right Cessation
- 1999-12-29 HK HK99106174A patent/HK1020956A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0001652A2 (hu) | Oxadiazolszármazékok, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények | |
HUP0204083A2 (hu) | 2-Amino-nikotin-amid-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények és VEGF receptor tirozin kináz inhibitorként való alkalmazásuk | |
HUP0002104A2 (hu) | Pirazolo[3,4-d]pirimidindion-származékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
DE60204452D1 (de) | Pyrazolo[1,5]pyridinderivate | |
HUP0303614A2 (hu) | Xantinszármazékok, előállításuk és alkalmazásuk gyógyszerként | |
MX9803954A (es) | Derivados de aminoacidos, composiciones farmaceuticas que contienen estos compuestos y procesos para prepararlos. | |
HUP0300783A2 (hu) | 17alfa-helyen gyűrűs acilcsoporttal észterezett 9 alfa-klór-6alfa-fluor-17alfa-hidroxi-16-metil-17béta-metoxi-karbonil-androszta-1,4-diének, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
ATE337316T1 (de) | Imidazo 1,2-aöpyridin-derivate zur prophylaxe und behandlung von herpes-infektionen | |
HUP0303415A2 (hu) | Triazolopiridinek, mint gyulladásgátló anyagok és ezeket tartalmazó gyógyszerkészítmények | |
ATE286500T1 (de) | 1,2,3,4-tetrahydroisochinolin-derivate | |
HUP0402026A2 (hu) | 5,6-Diaril-pirazin-2-amid-származékok mint CB1 antagonisták, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
EP0275005A3 (en) | Complex compounds of bioflavonoids with phospholipids, their preparation and use, and pharmaceutical and cosmetic compositions containing them | |
RU94042922A (ru) | Новые соединения, способы их получения, фармацевтическая композиция | |
NO20050668L (no) | 7,8,9,10-tetrahydro-6H-azepino6,7,8,9-tetrahydro-pyrido og 2,3-dihydro-2H-pyrrolo [2,1-B]-kinazolinon-derivater | |
DE69713151D1 (de) | Cyclosporinderivat, dessen herstellung und pharmazeutische zusammensetzung | |
CA2340405A1 (en) | Substituted 4-amino-2-aryl-pyrimidines, their production and use and pharmaceutical preparations containing same | |
DE59913103D1 (de) | Substituierte 4-amino-2-aryl-cyclopenta ädüpyrimidine, ihre herstellung, ihre verwendung und sie enthaltende pharmazeutische präparate | |
HUP0102515A2 (hu) | Ciklopeptidek, eljárás előállításukra, hatóanyagként azokat tartalmazó gyógyszerkészítmények és alkalmazásuk | |
SE9701304D0 (sv) | Compounds | |
MY114944A (en) | Propanolamine derivatives, processes for their preparation pharmaceuticals comprising these compounds, and their use | |
NO20010940L (no) | TAN-1057 derivater | |
TR199802042T2 (xx) | Yeni karbon asidi t�revleri, �retimleri ve kullan�mlar�. | |
HUP0402241A2 (hu) | Metformin és 4-oxo-butánsav kombinációját tartalmazó gyógyászati készítmény, és a készítmény alkalmazása diabétesz kezelésére | |
DE69402004D1 (de) | Beta-mercapto-propanamidderivate verwendbar zur Behandlung kardiovaskularer Krankheiten oder Erkrankungen | |
HUP0300557A2 (hu) | N-dezacetiltiokolkicin-származékok és ilyen vegyületeket tartalmazó gyógyászati készítmények |